Agilent Launches AI-Powered Cell Identification Module for BioTek…

Event summary

Agilent introduced the Gen5 AI cell identification module for BioTek automated cell imagers on September 29, 2026.
The module uses AI-based segmentation to reduce manual image-analysis steps and support consistent cell counting.
It supports label-free and fluorescence, live-cell and kinetic assays used in life science and pharmaceutical research.
The module integrates with existing BioTek Cytation and Lionheart automated imagers.

The big picture

Agilent's launch reflects the broader trend of integrating AI into laboratory workflows to enhance efficiency and reduce human error. The module's ability to streamline cell identification aligns with the increasing demand for higher-throughput imaging solutions in life science and pharmaceutical research. With $6.95 billion in revenue in fiscal year 2025, Agilent is positioning itself as a leader in automation and AI-driven laboratory technologies.

What we're watching

Adoption Pace: How quickly researchers will integrate AI-based segmentation into their existing workflows.
Competitive Response: Whether competitors will accelerate their own AI-driven imaging solutions.
Workflow Impact: The extent to which the module reduces manual steps and improves research efficiency.